Reply to the letter to the editor "Impella device use in high-risk PCI"

被引：1
|
作者：
Khalid, Nauman [1 ]
Rogers, Toby [1 ,2 ]
Shlofmitz, Evan [1 ]
Chen, Yuefeng [1 ]
Waksman, Ron [1 ]
机构：
[1] MedStar Washington Hosp Ctr, Sect Intervent Cardiol, Washington, DC USA
[2] NHLBI, Cardiovasc Branch, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
EUROINTERVENTION | 2019年 / 15卷 / 08期
关键词：
D O I：
10.4244/EIJ-D-19-00279R
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：732 / 732
页数：1
相关论文
共 50 条
  • [31] Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI
    Abu-Much, Arsalan
    Grines, Cindy L.
    Chen, Shmuel
    Batchelor, Wayne B.
    Zhao, Duzhi
    Falah, Batla
    Maini, Aneel S.
    Redfors, Bjorn
    Bellumkonda, Lavanya
    Bharadwaj, Aditya S.
    Moses, Jeffrey W.
    Truesdell, Alexander G.
    Zhang, Yiran
    Zhou, Zhipeng
    Baron, Suzanne J.
    Lansky, Alexandra J.
    Basir, Mir B.
    O'Neill, William W.
    Cohen, David J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 417
  • [32] High-risk PCI facilitated by levosimendan infusion and Impella CP support in ACS cohort-pilot study
    Turkiewicz, Karol
    Rola, Piotr
    Kulczycki, Jan Jakub
    Wlodarczak, Szymon
    Jastrzebski, Artur
    Pecherzewski, Maciej
    Furtan, Lukasz
    Barycki, Mateusz
    Doroszko, Adrian
    Wlodarczak, Adrian
    Lesiak, Maciej
    POLISH HEART JOURNAL-KARDIOLOGIA POLSKA, 2024, 82 (7-8): : 771 - 773
  • [33] INCIDENCE, PREDICTORS AND IMPACT OF POST-PROCEDURAL BLEEDING FOLLOWING IMPELLA-ASSISTED HIGH-RISK PCI
    Ranadive, Isha
    Koshy, Anoop Ninan
    Giustino, Gennaro
    Sartori, Samantha
    Barman, Nitin
    Dangas, George D.
    Sweeny, Joseph Michael
    Kini, Annapoorna Subhash
    Mehran, Roxana
    Sharma, Samin K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 852 - 852
  • [34] Outcome in Patients Undergoing High-Risk PCI Using Impella Circulatory Support: 10-Year Experience
    Vetrugno, Vincenzo
    Waqas, Muhammad
    Sandhu, Kully
    Mechery, Anthony
    Nadir, M. Adnan
    George, Sudhakar
    Zaphiriou, Alexander
    Lim, Sern
    Ludman, Peter
    Doshi, Sagar
    Townend, John
    Khan, Sohail
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B320 - B320
  • [35] Pancreaticogastrostomy for High-risk Gland After Pancreaticoduodenectomy: An Eligible Choice? Letter to the Editor
    Yang Sun Hu
    Dou Ke Feng
    Wang Hai Ying
    World Journal of Surgery, 2011, 35 : 224 - 225
  • [36] The role of Impella in high-risk percutaneous coronary intervention
    Moura-Ferreira, Sara
    Ladeiras-Lopes, Ricardo
    MBala, Domingas
    Rodrigues, Alberto
    Braga, Pedro
    Gama, Vasco
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2018, 37 (07)
  • [37] Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary Intervention
    Reddy, Pavan
    Merdler, Ilan
    Zhang, Cheng
    Cellamare, Matteo
    Ben-Dor, Itsik
    Bernardo, Nelson L.
    Hashim, Hayder D.
    Satler, Lowell F.
    Rogers, Toby
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 225 : 4 - 9
  • [38] The postoperative use of Impella as a ventricular assist device in high-risk patients undergoing coronary artery bypass surgery: A case series and comparison
    Sabra, Michel J.
    Andrews, Weston G.
    Crandall, Marie L.
    Pirris, John P.
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (01) : 113 - 117
  • [39] The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review
    Ichou, Jamal Ait
    Larivee, Natasha
    Eisenberg, Mark J.
    Suissa, Karine
    Filion, Kristian B.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 (07) : 1250 - 1260
  • [40] Reply to letter to editor "Cancer patients should be considered as a high-risk priority target in the COVID-19 vaccination process"
    Rajan, Shiv
    Akhtar, Naseem
    Kumar, Vijay
    Gupta, Sameer
    Chaturvedi, Arun
    Sharma, Sonali
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (03) : 455 - 455
12345